BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 17694175)

  • 1. A distal single nucleotide polymorphism alters long-range regulation of the PU.1 gene in acute myeloid leukemia.
    Steidl U; Steidl C; Ebralidze A; Chapuy B; Han HJ; Will B; Rosenbauer F; Becker A; Wagner K; Koschmieder S; Kobayashi S; Costa DB; Schulz T; O'Brien KB; Verhaak RG; Delwel R; Haase D; Trümper L; Krauter J; Kohwi-Shigematsu T; Griesinger F; Tenen DG
    J Clin Invest; 2007 Sep; 117(9):2611-20. PubMed ID: 17694175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PU.1 is regulated by NF-kappaB through a novel binding site in a 17 kb upstream enhancer element.
    Bonadies N; Neururer Ch; Steege A; Vallabhapurapu S; Pabst T; Mueller BU
    Oncogene; 2010 Feb; 29(7):1062-72. PubMed ID: 19966852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of Notch-1 expression decreases PU.1-mediated myeloid differentiation signaling in acute myeloid leukemia.
    Chen PM; Yen CC; Wang WS; Lin YJ; Chu CJ; Chiou TJ; Liu JH; Yang MH
    Int J Oncol; 2008 Jun; 32(6):1335-41. PubMed ID: 18497996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of c-myc gene accompanied by PU.1 deficiency in radiation-induced acute myeloid leukemia in mice.
    Hirouchi T; Takabatake T; Yoshida K; Nitta Y; Nakamura M; Tanaka S; Ichinohe K; Oghiso Y; Tanaka K
    Exp Hematol; 2008 Jul; 36(7):871-85. PubMed ID: 18375040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1.
    Rosenbauer F; Wagner K; Kutok JL; Iwasaki H; Le Beau MM; Okuno Y; Akashi K; Fiering S; Tenen DG
    Nat Genet; 2004 Jun; 36(6):624-30. PubMed ID: 15146183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dap12 expression in activated microglia from retinoschisin-deficient retina and its PU.1-dependent promoter regulation.
    Weigelt K; Ernst W; Walczak Y; Ebert S; Loenhardt T; Klug M; Rehli M; Weber BH; Langmann T
    J Leukoc Biol; 2007 Dec; 82(6):1564-74. PubMed ID: 17827340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggressive acute myeloid leukemia in PU.1/p53 double-mutant mice.
    Basova P; Pospisil V; Savvulidi F; Burda P; Vargova K; Stanek L; Dluhosova M; Kuzmova E; Jonasova A; Steidl U; Laslo P; Stopka T
    Oncogene; 2014 Sep; 33(39):4735-45. PubMed ID: 24121269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GATA-1 Inhibits PU.1 Gene via DNA and Histone H3K9 Methylation of Its Distal Enhancer in Erythroleukemia.
    Burda P; Vargova J; Curik N; Salek C; Papadopoulos GL; Strouboulis J; Stopka T
    PLoS One; 2016; 11(3):e0152234. PubMed ID: 27010793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Essential role of Jun family transcription factors in PU.1 knockdown-induced leukemic stem cells.
    Steidl U; Rosenbauer F; Verhaak RG; Gu X; Ebralidze A; Otu HH; Klippel S; Steidl C; Bruns I; Costa DB; Wagner K; Aivado M; Kobbe G; Valk PJ; Passegué E; Libermann TA; Delwel R; Tenen DG
    Nat Genet; 2006 Nov; 38(11):1269-77. PubMed ID: 17041602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimal PU.1 reduction induces a preleukemic state and promotes development of acute myeloid leukemia.
    Will B; Vogler TO; Narayanagari S; Bartholdy B; Todorova TI; da Silva Ferreira M; Chen J; Yu Y; Mayer J; Barreyro L; Carvajal L; Neriah DB; Roth M; van Oers J; Schaetzlein S; McMahon C; Edelmann W; Verma A; Steidl U
    Nat Med; 2015 Oct; 21(10):1172-81. PubMed ID: 26343801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PU.1 and CEBPA expression in acute myeloid leukemia.
    D'Alò F; Di Ruscio A; Guidi F; Fabiani E; Greco M; Rumi C; Hohaus S; Voso MT; Leone G
    Leuk Res; 2008 Sep; 32(9):1448-53. PubMed ID: 18308386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of PU.1 by methylation of distal regulatory elements and the promoter is required for myeloma cell growth.
    Tatetsu H; Ueno S; Hata H; Yamada Y; Takeya M; Mitsuya H; Tenen DG; Okuno Y
    Cancer Res; 2007 Jun; 67(11):5328-36. PubMed ID: 17545613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterozygous deletion of the PU.1 locus in human AML.
    Bonadies N; Pabst T; Mueller BU
    Blood; 2010 Jan; 115(2):331-4. PubMed ID: 19890096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PU.1 promotes cell cycle exit in the murine myeloid lineage associated with downregulation of E2F1.
    Ziliotto R; Gruca MR; Podder S; Noel G; Ogle CK; Hess DA; DeKoter RP
    Exp Hematol; 2014 Mar; 42(3):204-217.e1. PubMed ID: 24316397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced PU.1 expression causes myeloid progenitor expansion and increased leukemia penetrance in mice expressing PML-RARalpha.
    Walter MJ; Park JS; Ries RE; Lau SK; McLellan M; Jaeger S; Wilson RK; Mardis ER; Ley TJ
    Proc Natl Acad Sci U S A; 2005 Aug; 102(35):12513-8. PubMed ID: 16113082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological inhibition of the transcription factor PU.1 in leukemia.
    Antony-Debré I; Paul A; Leite J; Mitchell K; Kim HM; Carvajal LA; Todorova TI; Huang K; Kumar A; Farahat AA; Bartholdy B; Narayanagari SR; Chen J; Ambesi-Impiombato A; Ferrando AA; Mantzaris I; Gavathiotis E; Verma A; Will B; Boykin DW; Wilson WD; Poon GM; Steidl U
    J Clin Invest; 2017 Dec; 127(12):4297-4313. PubMed ID: 29083320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of concentration-dependent functions of PU.1 in hematopoiesis using mouse models.
    DeKoter RP; Kamath MB; Houston IB
    Blood Cells Mol Dis; 2007; 39(3):316-20. PubMed ID: 17629523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The actin-binding protein CORO1A is a novel PU.1 (SPI1)- and CEBPA-regulated gene with significantly lower expression in APL and CEBPA-mutated AML patients.
    Federzoni EA; Humbert M; Valk PJ; Behre G; Leibundgut EO; Torbett BE; Fey MF; Tschan MP
    Br J Haematol; 2013 Mar; 160(6):855-9. PubMed ID: 23252456
    [No Abstract]   [Full Text] [Related]  

  • 19. PU.1 regulates both cytokine-dependent proliferation and differentiation of granulocyte/macrophage progenitors.
    DeKoter RP; Walsh JC; Singh H
    EMBO J; 1998 Aug; 17(15):4456-68. PubMed ID: 9687512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sfpi1/PU.1 mutations in mouse radiation-induced acute myeloid leukaemias affect mRNA and protein abundance and associate with disrupted transcription.
    Brown NL; Finnon R; Bulman RA; Finnon P; Moody J; Bouffler SD; Badie C
    Leuk Res; 2011 Jan; 35(1):126-32. PubMed ID: 20638124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.